Sodium-glucose cotransporter 2 inhibitor use: A pharmaco-ergonomic qualification tool

Pharmaco-ergonomics implies tailoring the drug therapy to an individual patient's requirement(s). The development of sodium-glucose cotransporter 2 inhibitor (SGLT2-i) agents has impelled multiple clinical considerations, in the management of type-2 diabetes. This paper attempts to summarize th...

Full description

Bibliographic Details
Main Authors: Sanjay Kalra, A G Unnikrishnan, Manash Baruah, Pallavi Kawatra, Jignesh Ved
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Indian Journal of Endocrinology and Metabolism
Subjects:
Online Access:http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=5;spage=762;epage=764;aulast=Kalra